Literature DB >> 677980

Association between acute pancreatitis and malignant hypertension with renal failure.

C G Barcenas, M Gonzalez-Molina, A R Hull.   

Abstract

Of 42 patients with malignant hypertension seen in five years in our institutions, seven (17%) had acute pancreatitis. All patients with pancreatitis were black, all had renal failure, and six received dialysis. No particular drug was received by all patients, gallstones were excluded in the majority, and alcoholism was not a factor. Clinical acute pancreatitis persisted for several weeks and five patients died, three of them with pancreatic pseudocyts. Among 259 patients on long-term hemodialysis programs in the same time period, only two additional cases of acute pancreatitis were observed and related to chronic alcoholism. Acute pancreatitis is a frequent complication of malignant hypertension, and when it happens it is severe and commonly fatal.

Entities:  

Mesh:

Year:  1978        PMID: 677980

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Origin and development of exocrine pancreatic insufficiency in experimental renal failure.

Authors:  M M Lerch; P Hoppe-Seyler; W Gerok
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

2.  Acute pancreatitis in six non-transplanted uraemic children. A co-operative study from the French Society of Paediatric Nephrology.

Authors:  B Boudailliez; J L André; M Broyer; J C Davin; G Landthaler; J B Palcoux
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

3.  Malignant Hypertension Complicated with Necrotizing Pancreatitis After Starting Treatment: A Case Report.

Authors:  Shun Yoshida; Shotaro Takakuwa; Hiromi Kihira; Yasuhide Nishio; Manabu Haneda
Journal:  Am J Case Rep       Date:  2022-02-28

4.  The cytokine alterations/abnormalities and oxidative damage in the pancreas during hypertension development.

Authors:  Anna Kozłowska; Paweł Wojtacha; Michał Majewski; Maciej Równiak
Journal:  Pflugers Arch       Date:  2019-10-17       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.